Meng Kwek - Haw Par Executive
HAWPF Stock | USD 8.35 0.00 0.00% |
Executive
Mr. Kwek Meng Tiam is Regional General Manager of Underwater World Singapore Pte Ltd Haw Par Leisure Pte Ltd, a subsidiary of Haw par Corporation Ltd. He Joined Underwater World Singapore in 1991 as Maintenance Superintendent. Promoted to Operations Director in 2002 and General Manager of Underwater World Singapore Pte Ltd in 2005. Promoted to current position in 2010. Holds a Bachelor of Arts in Business Studies, The Open University, UK. since 2010.
Tenure | 14 years |
Phone | 65 6337 9102 |
Web | https://www.hawpar.com |
Haw Par Management Efficiency
Haw Par's management efficiency ratios could be used to measure how well Haw Par manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Jennifer Halchak | Organon Co | N/A | |
Charlotte PamerWieser | Novartis AG ADR | N/A | |
Samit MD | Bristol Myers Squibb | 55 | |
Scott Skellenger | Amgen Inc | N/A | |
Matthew Busch | Amgen Inc | 50 | |
Catherine Adams | Bristol Myers Squibb | 54 | |
Charles Sawyers | Novartis AG ADR | 62 | |
Annette Doherty | Pfizer Inc | N/A | |
Deborah Telman | Gilead Sciences | 59 | |
Tom Cavanaugh | Johnson Johnson | N/A | |
Daniel Karp | Organon Co | 46 | |
Arvind Sood | Amgen Inc | N/A | |
Mikael MD | Pfizer Inc | 66 | |
Eric MD | Merck Company | 64 | |
Steffen Lang | Novartis AG ADR | 57 | |
Ahn Poole | Bristol Myers Squibb | 49 | |
Rudolf Ertl | Gilead Sciences | 78 | |
Dalton III | Merck Company | 57 | |
Michael Bodner | Johnson Johnson | N/A | |
Shannon Klinger | Novartis AG ADR | 49 | |
Victoria Whyte | GlaxoSmithKline PLC ADR | N/A |
Management Performance
Return On Equity | 0.0424 | |||
Return On Asset | 0.0063 |
Haw Par Leadership Team
Elected by the shareholders, the Haw Par's board of directors comprises two types of representatives: Haw Par inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw Par's management team and ensure that shareholders' interests are well served. Haw Par's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw Par's outside directors are responsible for providing unbiased perspectives on the board's policies.
Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd | ||
Kun Chiew, Group Sec | ||
Say Chow, Group Finance Controller | ||
Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited | ||
Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare | ||
Tang Lee, Mang Communications | ||
Tang Chow, Human Director | ||
Brian Loo, Group Mang |
Haw Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw Par a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0424 | |||
Return On Asset | 0.0063 | |||
Profit Margin | 0.79 % | |||
Operating Margin | 0.19 % | |||
Current Valuation | (701.58 M) | |||
Shares Outstanding | 221.37 M | |||
Shares Owned By Insiders | 36.98 % | |||
Shares Owned By Institutions | 32.30 % | |||
Price To Earning | 15.92 X | |||
Price To Book | 0.65 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Haw Pink Sheet
Haw Par financial ratios help investors to determine whether Haw Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Haw with respect to the benefits of owning Haw Par security.